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ABSTRACT The present study used cocultures of clonally
derived B and T cells, together with an antigen reactive with the
membrane Ig of the clonal B cells, to address the issue of B-cell
differentiation requirements. The B cells were CH12.LX, an in
vitro grown subclone ofa murine B-cell lymphoma, which bears
surface IgM reactive with sheep erythrocytes. The T cells were
alloreactive T-helper-cell hybridomas. Very small numbers of
T-helper cells could induce differentiation of cloned B cells
without the presence of accessory cells, but such induction was
dependent upon the presence of the antigen recognized by the
B cell. Induced differentiation of the B cells did not depend on
metabolic activity of the T cells, and metabolically active T cells
could be replaced by fixed cells or by monoclonal antibody
reactive with the class II molecule of the B cell to deliver an
Ia-specific differentiative signal. T cells, or alloantibody that
reacted with the I-E molecule, induced differentiation of the B
cells; those that reacted with the I-A molecule did not. These
results define the minimal requirements for major histocom-
patibility complex-restricted, T-cell-mediated induction of B-
cell differentiation.
Antigen-specific interactions between B and T helper (TH)
lymphocytes can lead to differentiation and Ig secretion by
the B cell. These interactions involve recognition, by the TH
cell, of antigen associated with class II major histocompati-
bility complex (MHC) molecules on the surface of the B cell
(1). The series of steps by which antigen becomes associated
with class II molecules and thereby becomes visible to the TH
cell is termed antigen presentation. Macrophages and B cells
are able to present antigen, as are other cell types that bear
class II molecules (2-6). Thus, class II molecules are always
involved in TH-cell-B-cell interactions, and in some cases
class II molecules alone, without associated antigen, are
recognized by T cells. Alloreactive TH cells can mimic the
effect of syngeneic, antigen-specific, MHC-restricted TH
cells in inducing B-cell differentiation (7-10).
Previously published studies (9-11) have established that
cells of the murine B-cell lymphoma CH12 can be induced to
differentiate and secrete antibody, either nonspecifically by
mitogen or specifically by MHC-restricted TH cells plus the
antigen which reacts with the surface IgM of CH12. CH12
arose in a B10.H-2aH-4bp/Wts (2a4b) mouse (12). It bears
surface IgM reactive with sheep erythrocytes (SRBC; ref.
13). Only 0.1-1.0% of CH12 cells secrete antibody sponta-
neously, but culture with mitogen or with SRBC plus spleen
cells containing TH cells of appropriate specificity and H-2
haplotype increased this proportion 10- to 20-fold. Antigen-
primed TH cells were able to induce differentiation of CH12
only if derived from mice that share the I-Ek allele with CH12
but not if derived from mice that match with CH12 (k allele)
only in the I-A subregion of H-2. Similar results were
obtained with alloreactive T-cell lines (11), although flow
cytometric analysis showed that CH12 cells bear approxi-
mately equal amounts of the I-Ek and I-Ak antigens (14). If
SRBC were omitted from the cocultures of T and B cells,
B-cell differentiation did not occur.
Further interpretation of the data was precluded by the
lack of homogeneity in the B-cell and TH-cell populations
used; the CH12 cells were harvested from the ascites fluid of
2a4b mice bearing the CH12 tumor, and the TH cells were
mouse spleen cells that had either been antigen-primed in
vivo or allostimulated in vitro. Thus, the B cells contained a
small number of host-derived cells such as macrophages, and
the TH cells were heterogeneous in cell type and specificity.
To study antigen-specific, MHC-restricted interaction in a
defined experimental system, we have derived an in vitro
subclone of CH12, called CH12.LX, and have studied its
interaction with a series of TH-cell hybridomas alloreactive
with the I-Ak or I-Ek molecules. In the experiments reported
here, we have found that differentiation of the clonal B cells
required the presence of SRBC and occurred only in the
presence of TH cells that react with the I-Ek molecule.
CH12.LX cells were recognized by either I-Ak or I-Ek
alloreactive TH cells, and both types of TH cells were
activated to secrete interleukin 2 (IL-2) by contact with
CH12.LX. B-cell differentiation required the presence of
only very small numbers of TH cells, which did not need to
be metabolically active. The presence of SRBC did not
detectably affect the response ofthe TH cells to CH12.LX but
was necessary to induce differentiation ofthe B cells. Finally,
we found that monoclonal antibodies specific for the I-E
molecule could substitute for I-Ek-reactive T cells in deliv-
ering a differentiative signal to CH12.LX cells.
MATERIALS AND METHODS
B Cells. The surface u'a-, Ly-l+ B-cell clone CH12.LX
was derived by single-cell cloning of the murine B-cell
lymphoma CH12, which arose in 2a4b mice. The derivation,
phenotype, and functional properties of CH12 have been
described (12, 14). CH12.LX cells were grown and main-
tained in suspension culture in RPMI 1640 medium containing
10% heat-inactivated fetal calf serum, 300 ,ug of fresh
glutamine per ml, 0.04 mM 2-mercaptoethanol, and antibiot-
ics (B-cell medium).
TH Cells. The I-Ek-specific alloreactive TH-cell hybrido-
mas E2.21, E2.23, E2.26, and E4.26 and the I-Ak-specific
alloreactive TH-cell hybridoma BDK4.10.13 were provided
by A. Augustin (15). The I-Ak-specific alloreactive TH-cell
hybridoma 2h405.2 and the keyhole limpet hemocyanin
(KLH)-specific, I-Ak_ or I-Ek-restricted TH-cell hybridomas
Abbreviations: LPS, lipopolysaccharide; IL-2, interleukin 2; KLH,
keyhole limpet hemocyanin; MHC, major histocompatibility com-
plex; SRBC, sheep erythrocytes; TH, T helper; 284 , BlO.H-28H-
4bp/Wts; pfc, plaque-forming colony(ies).
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2DKK21.6, 2DKK45.5, SKK9.11, and KK4.5 were provided
by P. Marrack (16).
Antibodies. The monoclonal alloantibodies used in these
studies were 10-2.16 and 10-3.6.2 (anti-I-Ak; ref. 17) and
14-4-4S and 17-3-3 (anti-I-Ek; ref. 18). Antibodies were used
as tissue culture supernatants from hybridomas provided by
the American Type Culture Collection and were diluted in
B-cell medium for addition to test cultures.
Assays for IL-2 Production. To assay TH clones for IL-2
production, 1 x 10- TH cells were cultured in 96-well
microtiter plates with 5 x 104 CH12.LX cells or 1 x 106 spleen
cells from mice of appropriate strains in a volume of 0.2 ml.
In experiments measuring IL-2 production by KLH-specific
TH cells, 1-100 gg ofKLH (Calbiochem) per ml was included
in the cultures. Culture supernatants were harvested after 24
hr and assayed for IL-2 as described (19). In some cases,
culture supernatants were harvested from cultures set up to
assay B-cell differentiation; in such cases, cultures contained
SRBC, and supernatants were harvested at 24 and at 48 hr.
Assay for B-Cell Differentiation. To measure induced dif-
ferentiation, 2 x 10- CH12.LX B cells were cultured with
or without TH cells in 2 ml of B-cell medium in Costar 24-well
plates. Cultures were incubated at 37°C in an atmosphere of
5% CO2 in air. TH cells, at all doses used, were exposed to
1500 R (1 R = 0.258 mC/kg) of y-irradiation prior to their
addition to cultures. Cultures were incubated for 48 hr. SRBC
(ASA Biological Products, Winston-Salem, NC) were
washed in RPMI 1640 medium three times before use; 106
were included in each culture, except for those labeled "no
SRBC." Mitogen-stimulated cultures contained 50 ,g of
lipopolysaccharide (LPS) (Difco) per ml. All cultures were
set up in duplicate. Direct hemolytic plaque-forming colonies
(pfc) in CH12.LX cultures were determined by the method of
Cunningham and Szenberg (20).
Preparation of Fixed TH Cells. Paraformaldehyde-fixed TH
cells were prepared by the method of Allen and Unaue (21).
Cells were washed extensively to remove any residual
paraformaldehyde before addition to cultures. In separate
experiments, it was determined that fixed TH cells did not
secrete detectable amounts of IL-2.
RESULTS
Activation of Alloreactive TH Cells by Recognition of Ia
Antigens of CH12.LX. To determine if CH12.LX could
activate TH-cell hybridomas, 10 different TH-cell hybrid-
omas, alloreactive with either I-Ak or I-Ek or specific for
KLH presented in the context of either I-Ak or I-Ek, were
cocultured with CH12.LX cells or with spleen cells from mice
of various H-2 haplotypes. Culture supernatants were as-
sayed for IL-2 production. Results of this experiment are
presented in Tables 1 and 2. Several of the clones produced
small but detectable quantities of IL-2 spontaneously, but all
responded with increased IL-2 production when cultured
Table 2. IL-2 production (units/ml) by KLH-specific
TH-cell hybridomas
KLH, ,ug/ml
THcell hybridoma (specificity) 0 1 10 100
2DKK21.6 (I-Ek + KLH) <10 10 40 80
2DKK45.5 (I-Ek + KLH) <10 40 160 640
SKK9.11 (I-AZ + KLH) <10 10 40 160
KK4.5 (I-Ak + KLH) <10 10 80 160
CH12.LX cells were used as presenting cells.
with 2a4b (H-2a) splenocytes (Table 1). Responses to spleno-
cytes of other haplotypes were consistent with the specificity
of each clone. The absolute amount of IL-2 produced varied
among the clones over about a 40-fold range, but, in all cases,
the response to CH12.LX cells was indistinguishable from
the response to H-2a splenocytes. CH12.LX cells do not
themselves secrete IL-2, either spontaneously or when in-
duced to differentiate (data not shown). We conclude that
CH12.LX cells are as capable of stimulating the response of
alloreactive TH cell clones as are normal spleen cells. Since
CH12.LX and the TH-cell hybridomas are clonal populations,
uncontaminated by other cell types, data presented in Table
1 also demonstrate that the stimulation of alloreactive TH
cells by CH12.LX does not require the presence ofaccessory
cells.
Data presented in Table 2 demonstrate that CH12.LX cells
are also capable of presenting KLH to KLH-specific, I-Ak_
or I-Ek-restricted TH-cell hybridomas. No IL-2 was secreted
by any of the four KLH-specific hybridomas in the absence
of KLH. In addition, CH12.LX cells do not activate I-Ab-
restricted, KLH-specific TH cells to secrete IL-2, either in the
presence or absence of KLH (22). Thus, CH12.LX cells do
not nonspecifically activate T cells to secrete IL-2.
Differentiation of CH12.LX Cells Induced by Alloreactive
TH-Cell Hybridomas. To test whether alloreactive TH-cell
hybridomas could induce CH12.LX cells to differentiate, test
cultures were established containing 2 x 10- CH12.LX cells,
graded numbers of 1500-R irradiated TH cells (from 50 to
500,000), and 106 SRBC in a volume of 2 ml. Replicate
cultures were established that did not contain SRBC. Con-
trols included cultures containing CH12.LX cells with 50 1g
of LPS per ml (positive control) and CH12.LX cells either
alone or with SRBC (negative controls). No difference has
been noted between the number of pfc produced in cultures
containing CH12.LX cells plus SRBC and those containing
CH12.LX cells alone (data not presented). After 24 and 48 hr,
the number of viable CH12.LX cells was determined and
direct hemolytic pfc were counted for each culture. Data are
expressed as pfc per culture or pfc per 106 recovered
CH12.LX cells. The former was used in experiments in which
105or more TH cells were included in some cocultures, since
it was difficult to distinguish between clonal B and T cells
Table 1. IL-2 production (units/ml) by alloreactive TH-cell hybridomas
Presenting cells*
TH-cell hybridoma B6t 3Rt 4Rt HTHt 2a4bt CH12.LX
(specificity) Nonet (bbbb) (bbbk) (kkkb) (kkkk) (kkkk) (kkkk)
E2.21 (I-Ek) 20 20 80 10 40 160 80
E2.23 (I-Ek) <10 <10 ND ND 20 20 20
E2.26 (I-Ek) 10 10 30 10 160 80 80
E4.26 (I-Ek) 10 10 ND ND 20 20 40
BDK4.10.13 (I-Ak) <10 <10 10 40 160 160 80
2h405.2 (I-Ak) <10 20 <10 160 880 800 1280
ND, not done.
*B6 = C57BL/6; 3R = B1O.A (3R); 4R = B1O.A (4R); HTH = HTH/Ao. Ia alleles (Ap4AaEpE&) are shown in parentheses.
tSpleen cells.
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FIG. 1. Differentiation of CH12.LX induced by alloreactive TH-cell hybridomas. CH12.LX cells were cocultured with varying numbers of
irradiated TH cells for 48 hr. Controls were cultures containing CH12.LX plus SRBC only (v) or CH12.LX plus 50 ,ig of LPS per ml (A).
a-, Cultures containing SRBC; e---e, cultures without SRBC. The TH-cell hybridomas E2.23 (A) and E4.26 (B) are alloreactive with I-Ek.
The THcell hybridoma 2h405.2 (C) is alloreactive with I-Ak. Each point represents the mean + SEM of values obtained from six separate
experiments. Within each experiment, each culture was performed in duplicate.
when counting the cells. Figs. 1 and 2 show that CH12.LX
differentiated to secrete hemolytic antibody when cultured
with any of four clones of TH cells reactive with the I-Ek
molecule, but that this occurred only if SRBC were included
in the cultures (Fig. 1 A and B; Fig. 2A). Differentiation did
not occur when I-Ak-specific TH cells were used, even if
SRBC were also present (Fig. 1C; Fig. 2B). Statistical
analysis (Student's t test) of the data presented in Fig. 1,
pooled from six separate experiments, showed that at all
doses of TH cells added, addition of I-Ek-specific TH cells
induced a significant increase in pfc formation compared to
the negative control (P < 0.01). If SRBC were not included
in the cultures, differentiation of CH12.LX was not signifi-
cantly increased. Similarly, addition of I-Ak-reactive TH
cells, either with or without SRBC, did not significantly
increase CH12.LX differentiation. As few as 50 irradiated
cells of I-Ek-reactive hybridomas added to 2 x 105 CH12.LX
cells caused a significant effect. This contrasted with the
failure of up to 5 x 105 I-Ak-reactive TH cells to induce
differentiation. The effect could not be ascribed to prolifer-
ation of the TH cells, since they had been heavily irradiated
prior to culture.
The addition of 5 x 102-5 x 104 cells of the H-2a macro-
phage tumor UNC-2 (12) to cocultures of CH12.LX cells and
the I-Ak_ or I-Ek-reactive TH-cell hybridomas studied here
neither increased TH-cell-mediated differentiation of CH-
12.LX nor reversed the inability of I-Ak-specific TH cells to
deliver a differentiative signal, although UNC-2 stimulates
IL-2 production by alloreactive and KLH-specific TH-cell
hybridomas (G.A.B., unpublished data). The failure of I-Ak_
specific TH cells to induce CH12.LX cells to differentiate thus
cannot be ascribed to a need for accessory cells or their
secreted products.
Differentiation of CH12.LX Induced by Fixed TH Cells and
Antigen. To this point, the data had established that activa-
tion of the TH cell to produce IL-2, resulting from the
T-cell-B-cell interaction, was not sufficient to induce differ-
entiation ofCH12.LX B cells. However, they did not exclude
the possibility that metabolic activation of the TH cell was
necessary for induction of B-cell differentiation. To test this,
we attempted to induce B-cell differentiation using paraform-
aldehyde-fixed TH cells, which we have found are no longer
capable of secreting IL-2. The results obtained are presented
in Fig. 3. When 5 x 104 fixed TH cells of the I-Ek-alloreactive
TH clone E2.21, together with 106 SRBC, were added to
CH2.LX cells at 0 and 24 hr, we saw a degree of B-cell
differentiation at 48 hr of coculture similar to that observed
with a single dose of an equal number of irradiated, viable
E2.21 cells. It was necessary to add a second dose offixed TH
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FIG. 2. Differentiation of CH12.LX
cells induced by alloreactive TH-cell hy-
bridomas. Cultures were prepared as in
Fig. 1. (A) Cultures contained the I-Ek-
alloreactive TH-cell hybridoma E2.26 (o)
no SRBC or E2.21 (0). o---o and *---e, cultures in
. _ which SRBC were not included. (B) Cul-
tures contained the I-Ak-alloreactive TH-
K+SRBC cell hybridoma BDK4.10.13, either with
(a-*) or without (e---e) SRBC. Each
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FIG. 3. Differentiation ofCH12.LX induced by fixed TH cells and
antigen. Cultures were prepared as in Fig. 1, with 5 x 104 TH cells
added per culture. Paraformaldehyde-fixed TH cells were prepared
by the method of Allen and Unanue (21). These TH cells do not
secrete IL-2. Cultures were assayed at 48 hr of culture. All cultures
contained 106 SRBC. Results represent the mean values obtained
from duplicate cultures and are representative of two similar
experiments.
cells induced a similar degree of differentiation of CH12.LX
cells at 24 hr of culture, the effect of the fixed cells decreased
by 48 hr (data not shown). Cells of the I-Ak-reactive TH clone
BDK4.10.13 failed to induce B-cell differentiation. There was
no effect of fixation, irradiation, or dose of T cells added.
Induction of Differentiation in CH12.LX Cells Using Mono-
clonal Antibodies. Since the above results had demonstrated
that metabolically active TH cells were not necessary to
deliver a differentiative signal, we attempted to use anti-class
II monoclonal antibodies to substitute for TH cells. CH12.LX
cells were cultured as above, but TH cells were not added to
these cultures. Instead, two monoclonal antibodies specific
for I-Ak (10-2.16 and 10-3.6.2) and two specific for I-Ek
(14-4-4S and 17-3-3) were used at varying dilutions in the
cultures. Fig. 4 shows that antibodies specific for I-Ek were
effective in inducing differentiation; a 4-fold increase in pfc
was seen using up to a 1:10,000 dilution of 14-4-4S hybridoma
tissue culture supernatant (Fig. 4A). Antibodies specific for
I-Ak, however, were ineffective in inducing differentiation.
As with the differentiation induced by TH cell clones,
antibody-induced differentiation of CH12.LX required the
presence of SRBC (Fig. 4B).
DISCUSSION
These results confirm and extend the data that were gener-
ated from studies of the interaction of ascites-derived CH12
cells with heterogeneous populations of splenic TH cells
(9-11). By using monoclonal populations of T cells and B
cells, we have excluded involvement of any other cells in the
responses measured. Two major conclusions may be drawn
from these studies. (i) During the interaction between
CH12.LX and alloreactive TH cells, the B cell serves as a
transmitter and a receiver of differentiative signals. (ii) The
number of TH cells needed to induce differentiation of CH-
12.LX is very small and the TH cells need not be metaboli-
cally active.
Alloreactive TH cells that recognized either the I-Ak or the
I-Ek antigens on the surface of CH12.LX were stimulated
upon coculture to secrete IL-2, and this stimulation occurred
whether or not SRBC, which bind to the surface IgM of
CH12.LX, were also included in the culture. By contrast,
differentiation of the B cells required that SRBC be present
and was only induced by those TH cells that were reactive
with the I-Ek molecule. The TH cells that reacted with I-Ak
molecules, although themselves stimulated to secrete IL-2,


















FIG. 4. Induction of differentiation in CH12.LX cells using
monoclonal antibodies. CH12.LX cells were cultured as in Fig. 1, but
TH cells were not included in these cultures. Monoclonal anti-I-Ak
(10-2.16 and 10-3.6.2) and anti-I-Ek (14-4-4S and 17-3-3) antibodies
(AB) were used as tissue culture supernatants at varying dilutions in
the cultures. SRBC (106) were included in all cultures in A. In B,
hatched bars represent cultures containing 106 SRBC, and open bars
represent cells cultured without SRBC. Results represent mean
values obtained from duplicate cultures and are representative of
three similar experiments.
SRBC. CH12.LX, like the cells of its parent lymphoma
CH12, bears similar amounts of cell-surface I-Ek and I-Ak
antigens, as measured by flow cytometric analysis and
two-dimensional gel electrophoresis (M. McMillan, G.A.B.,
and J. Frelinger, unpublished data).
Only a very small number of TH cells, alloreactive with
I-Ek, were needed to induce differentiation of CH12.LX in
the presence of SRBC. Addition of SRBC to cultures con-
taining 2 x 105 CH12.LX cells alone did not induce differ-
entiation, whereas the inclusion of as few as 50 (0.025%)
irradiated TH cells specific for I-Ek resulted in the generation
of a significant number of antibody secreting pfc (Figs. 1 and
2). The total number of pfc generated greatly exceeded the
number of TH cells added, implying that each TH cell
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kines nor accessory cells were required, a point emphasized
by the findings that fixed T cells (Fig. 3) and Ia-specific
monoclonal antibodies (Fig. 4) could substitute for metabol-
ically active T cells in delivering a differentiative signal to
CH12.LX. In all cases, differentiation of the B cell occurred
when ligand bound to the I-E molecule and antigen bound to
the surface IgM. We conclude that signals generated by these
binding events are transduced across the membrane by these
receptor molecules and that the two signals are the minimal
requirements for MHC-restricted, antigen-specific induction
of CH12.LX cells to differentiate and secrete antibody.
Our data do not preclude the possibility that CH12.LX
cells can respond to lymphokines. They argue only that
factors secreted by the TH cells, in response to the T-cell-B-
cell interaction, are neither sufficient nor necessary to acti-
vate CH12.LX cells to differentiate to antibody secretion.
Our data do not relate to control of proliferation; CH12.LX,
like all other immortal clones of cells, maintains a high level
of metabolic activity and replicates continuously. It is pos-
sible that this high level of metabolic excitation is a necessary
prerequisite for rendering the cell receptive to the differenti-
ative signals that we have described.
It may be that the relatively simple mechanism that we
have elucidated for inducing CH12.LX cells to differentiate
is a characteristic of Ly-1 B cells. CH12 and all other B-cell
lymphomas of the CH series (12, 23) express the Ly-1 surface
antigen. This is a distinguishing characteristic of a small
population of normal B cells, recently shown to represent a
distinct lineage (24) and largely responsible for the production
of autoantibodies such as those directed against bromelain-
treated mouse erythrocytes (Br-MRBC) and DNA (25, 26).
The spleens of all strains ofnormal, unimmunized mice tested
contain B cells that secrete antibody hemolytic for SRBC and
Br-MRBC; all such B cells are Ly-l (25-27). These doubly
hemolytic B cells are present in 2a4b mice at a frequency of
about 1:3000, and we have recently shown that about half of
these B cells bear surface Ig ofthe same idiotype as CH12.LX
(27). Thus, CH12.LX, although a neoplastic cell, expresses
many of the characteristics of a rather frequent type of
normal, Ly-1 splenic B cell.
We do not have enough data to interpret or explain the
observation that CH12.LX cells cannot be triggered to
differentiate by way of the I-A molecule. Alloreactive TH cell
hybridomas respond equally well to the I-Ek and the I-Ak
molecules on CH12.LX cells (Table 1). This finding demon-
strates that, at least so far as being recognizable by TH cells
is concerned, I-A and I-E molecules are normal and similarly
available on the surface of CH12.LX cells. Nonetheless,
differentiation of the B cells resulted only from those inter-
actions with TH cells that involved the I-E molecule. There
are several possible explanations for this result. There may
be an aberration in the transmembrane or cytoplasmic do-
main of the A, or A# chain of CH12.LX. Alternatively, there
may be clonal specialization of function of B-cell Ta mole-
cules, a phenomenon not observed previously because the
appropriate clonal B-cell models were not available. Finally,
since both of the anti-I-Ak monoclonal antibodies used in
experiments presented in Fig. 4 are specific for determinants
present on the ,B chain of the I-A molecule (28) and since the
location of the determinants recognized by the I-Ak- and
I-Ek-alloreactive T cells used in these studies is unknown, the
possibility exists that the observed preference of CH12.LX
for receiving differentiative signals by way of its I-E mole-
cules may actually be a preference for signals generated by
binding of the a rather than / chain of the B-cell Ia molecules.
However, of the two anti-I-Ek monoclonal antibodies used
successfully to stimulate the differentiation of CH12.LX
cells, one (14-4-4S) recognizes an epitope present on the E,
chain, whereas the other (17-3-3S) is specific for a determi-
nant present on the Ep chain (28). Whatever the underlying
reason for the failure of interactions involving I-A, this failure
demonstrated that activation of TH cells and the associated
production of lymphokines was not sufficient to cause B-cell
differentiation.
Our results complement those of Lanzavecchia (6), who
used clones of virus-transformed B cells to demonstrate their
ability to present specific antigen to T cells. Using the
CH12.LX B cell clone and TH-cell clones, we have also
demonstrated the ability of B cells to present antigen and
have shown the consequences of this interaction for the B
cell, resulting in differentiative signals delivered to the B cell
by way of its class II molecule and its surface Ig. The use of
model systems employing clonal populations ofT and B cells
should prove valuable in further defining the nature and
consequences of T-cell-B-cell interactions.
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